Myocardial Infarction

What a myocardial infarction is

The heart is a muscle that never rests, and like any working muscle it needs a continuous supply of oxygen and fuel. That supply arrives through the coronary arteries, which branch off the aorta just above the aortic valve and wrap over the surface of the heart. A myocardial infarction occurs when one of these arteries — or a branch of it — is abruptly blocked, cutting off blood to the muscle it feeds. Deprived of oxygen, that territory of myocardium first stops contracting and then, if flow is not restored quickly, dies. The Latin roots are literal: myo- (muscle), -cardial (heart), infarction (tissue death from blocked blood supply).

The overwhelming majority of infarctions are not caused by an artery slowly clogging shut. They are caused by plaque rupture. Atherosclerotic plaques build up silently over decades in the artery wall, and the dangerous ones are not necessarily the bulkiest — they are the ones with a thin fibrous cap over a soft, lipid-rich core. When that cap tears, the bloodstream is suddenly exposed to highly thrombogenic material. Platelets stick and aggregate within seconds, the coagulation cascade fires, and a thrombus can grow from a trickle-narrowing to a complete coronary occlusion in minutes. A vessel that was only 40-50% narrowed the day before — invisible to a stress test — can be the one that kills.

The ischemic cascade: seconds to hours

What happens downstream of the clot is a tightly ordered sequence sometimes called the ischemic cascade. Cardiac muscle has almost no oxygen reserve, so the consequences begin almost immediately:

• Seconds. Aerobic metabolism halts. The myocyte switches to anaerobic glycolysis, lactate accumulates, and intracellular pH falls.
• ~10-60 seconds. ATP drops below the level needed for contraction. The affected wall stops squeezing and may even bulge outward in systole (dyskinesis) — visible on echocardiography as a regional wall-motion abnormality long before the patient feels anything.
• Minutes. The Na⁺/K⁺-ATPase fails, cells swell, and intracellular calcium rises uncontrollably. The membrane potential becomes unstable, setting the stage for arrhythmia.
• ~20-30 minutes. Injury becomes irreversible. Membranes rupture, mitochondria are destroyed, and the cell can no longer recover even if blood flow returns.
• Hours. The wavefront of necrosis advances from the inner subendocardium — the layer furthest from the surface vessels and therefore most vulnerable — outward toward the epicardium. By 4-6 hours of complete occlusion, a transmural (full-thickness) infarct is essentially complete.

This subendocardium-to-epicardium wavefront phenomenon is why timing matters so much. The longer the artery stays shut, the more of the salvageable outer muscle is lost. It is also why the bedside mantra is time is muscle: every 30 minutes of delay measurably worsens the eventual scar size and survival.

The numbers that define it

Coronary blood flow at rest is roughly 250 mL/min — about 5% of cardiac output for an organ that is only 0.5% of body weight — and it can quadruple during exercise. The heart extracts about 70-80% of the oxygen from that blood even at rest (compared with ~25% for the body as a whole), so there is very little extraction reserve; the only way to meet higher demand is to increase flow. When a clot blocks that flow, demand cannot be met by any compensation, and the deficit is felt at once.

The fourth Universal Definition of Myocardial Infarction requires a rise and/or fall in cardiac troponin with at least one value above the 99th-percentile upper reference limit, plus evidence of ischemia (symptoms, ECG changes, imaging, or angiographic thrombus). High-sensitivity troponin assays can detect concentrations in the nanograms-per-litre range and turn positive within 1-3 hours, which is why modern rule-out protocols can safely discharge low-risk chest-pain patients in as little as 1-2 hours using serial measurements.

STEMI versus NSTEMI versus angina

Acute coronary syndromes form a spectrum from reversible ischemia to full-thickness death. The ECG and troponin together place a patient on that spectrum and dictate how urgently the artery must be opened. The distinctions are clinically decisive — a STEMI goes to the cath lab immediately, while stable angina is managed with medication and lifestyle change.

Feature	STEMI	NSTEMI	Unstable angina	Stable angina
Artery	Complete, persistent occlusion	Partial / transient occlusion	Partial / transient occlusion	Fixed narrowing (~>70%)
Cell death	Yes — transmural	Yes — subendocardial	No (ischemia only)	No
ECG	ST elevation / new LBBB	ST depression, T inversion	ST depression, T inversion	Often normal at rest
Troponin	Elevated	Elevated	Normal	Normal
Symptom trigger	At rest, prolonged	At rest or minimal exertion	At rest / crescendo pattern	Predictable exertion, relieved by rest
Immediate treatment	Emergency reperfusion (PCI / lysis)	Antithrombotics + early angiography	Antithrombotics + risk-based angiography	Medical therapy, elective workup

The ECG localizes the injury because each lead views a different wall of the heart. ST elevation in the inferior leads (II, III, aVF) points to the right coronary artery; the anterior leads (V1-V4) point to the left anterior descending — the so-called "widow-maker" because an LAD occlusion threatens a large swath of the left ventricle. Reciprocal changes (depression in opposite leads) help confirm a true infarct rather than a mimic like pericarditis.

How it presents — and how it hides

The textbook presentation is crushing, central chest pressure, often radiating to the left arm, jaw, or back, lasting more than 20 minutes and unrelieved by rest, accompanied by sweating, nausea, and a sense of doom. But a substantial fraction of infarctions are atypical or "silent." Women, older adults, and people with diabetes (whose autonomic neuropathy blunts pain) more often present with breathlessness, fatigue, indigestion-like discomfort, or simply collapse. Roughly one in five infarctions is clinically silent, discovered only later as unexplained Q waves on a routine ECG or a scar on imaging. This is precisely why the objective tests — troponin and ECG — carry so much weight rather than symptoms alone.

Reperfusion — and its own injury

The treatment of a STEMI is to reopen the artery as fast as possible, either mechanically with primary percutaneous coronary intervention (PCI) — threading a catheter to the blockage, inflating a balloon, and deploying a stent — or pharmacologically with a thrombolytic ("clot-busting") drug such as tenecteplase when PCI cannot be delivered quickly. Guidelines set a door-to-balloon target under 90 minutes and a door-to-needle target for lysis under 30 minutes. Antiplatelet agents (aspirin plus a P2Y12 inhibitor) and anticoagulants are given to stop the thrombus from re-forming.

Restoring flow is lifesaving, but it is not free. The sudden return of oxygenated blood to tissue that has been starved triggers ischemia-reperfusion injury: a burst of reactive oxygen species, calcium overload, and opening of the mitochondrial permeability transition pore that can kill cells that survived the ischemia itself. Reperfusion can also unmask arrhythmias and cause transient "stunned" myocardium that contracts poorly for days before recovering. The net effect is still strongly favorable — the muscle saved vastly outweighs the reperfusion injury — but it explains why outcomes are not perfect even when the artery is opened.

The aftermath: scar, remodeling, and heart failure

Dead myocardium cannot regenerate. Over the following weeks, neutrophils and then macrophages clear the necrotic debris, fibroblasts move in, and the infarct is replaced by a collagen scar that is mechanically strong but electrically silent and contractile-dead. The danger window for mechanical rupture is days 3-7, when the infarct has softened but the scar has not yet formed: free-wall rupture causes fatal tamponade, septal rupture creates an acute shunt, and papillary-muscle rupture causes torrential mitral regurgitation. Beyond the acute phase, the ventricle undergoes remodeling — the infarcted wall thins and may dilate into an aneurysm, while the remaining muscle hypertrophies and the chamber enlarges. This remodeling, driven partly by the renin-angiotensin-aldosterone system, is why ACE inhibitors, beta-blockers, and aldosterone antagonists are cornerstones of post-MI therapy: they blunt the remodeling that otherwise progresses to chronic heart failure.

Why arteries rupture: the risk substrate

• Atherosclerosis is the soil. Decades of LDL deposition, endothelial dysfunction, and inflammation build the vulnerable plaque that eventually ruptures.
• Smoking, diabetes, hypertension, and dyslipidemia accelerate plaque formation and destabilize existing plaques; smoking also makes blood more thrombogenic and triggers spasm.
• Inflammation matters independently — markers like high-sensitivity CRP predict events, and anti-inflammatory therapy reduces them, reframing atherosclerosis as partly an immune disease.
• Cocaine and other stimulants can cause infarction in young people with clean arteries through intense coronary spasm and a surge in demand.
• Type 2 (supply-demand) mechanisms — severe anemia, sustained tachyarrhythmia, hypotension, or sepsis — can infarct myocardium without any acute plaque event, especially where a fixed narrowing already limits flow.

It is worth distinguishing infarction from related cardiac emergencies. A cardiac arrest is the heart stopping as a pump — often triggered by the ventricular fibrillation an MI provokes, but the two are not synonymous. Angina is reversible ischemic pain without cell death. And conditions like Takotsubo (stress) cardiomyopathy can perfectly mimic a STEMI on presentation yet show open arteries at angiography, underscoring why the full diagnostic picture — not any single sign — defines a true infarction.

This article is educational and is not medical advice. Chest pain or suspected heart attack is an emergency — call your local emergency number immediately.